Can a gentle tap replace the Eye-Pressure gold standard?
NCT ID NCT05147610
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This trial tests whether the Icare200, a handheld rebound tonometer, measures eye pressure as accurately as the Goldmann applanation tonometer, the current gold standard. Adults needing eye-pressure checks will have their pressure measured with both devices, plus an air-puff tonometer, to see how well the results agree. The study also looks at how corneal thickness, body mass index, and patient stress affect readings. If the Icare200 proves reliable, it could make eye-pressure screening easier for people who have difficulty with traditional methods.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Icare200 rebound tonometer (a handheld device that measures eye pressure by gently tapping the cornea)
- What this could lead to
- If the Icare200 proves as accurate as the gold-standard test, it could make eye-pressure screening easier and more accessible, especially for people who struggle with traditional methods.
- What could go wrong
- This is a diagnostic accuracy study, not a treatment trial. The Icare200 may not match the gold standard closely enough, and results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA EYE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Clermont-Ferrand
Clermont-Ferrand, 63000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.